Biomarker: A Potential Novel Therapeutic Target for Early Detection of Lung Cancer

Vinit Vaidya

Department of Botany, Thakur College of Science and Commerce, Thakur Village, Kandivali (East), Mumbai-400101, India.

Vedaant Bhandary *

Department of Botany, Thakur College of Science and Commerce, Thakur Village, Kandivali (East), Mumbai-400101, India.

Faisal Qureshi

Department of Botany, Thakur College of Science and Commerce, Thakur Village, Kandivali (East), Mumbai-400101, India.

Priyanshi Vishwakarma

Department of Botany, Thakur College of Science and Commerce, Thakur Village, Kandivali (East), Mumbai-400101, India.

*Author to whom correspondence should be addressed.


Abstract

Cancer is a deadly disease which can affect any part of our body. Many cancers like Lung cancer, Breast cancer are present but, in our article, we mainly focused on Lung Cancer which has a high mortality rate. There are 2 types of Lung cancers mainly NSCLC (non-small cell lung cancer) and SCLC (small cell lung cancer) and although treatments are available, the survival rate is still very low due to the late detection of these cancers. Biomarkers are biological genes which show changes when a tumor formation takes place. Our article provides an overview of Lung cancer, treatments and mainly focuses on potential biomarkers and also suggests some futuristic ideas that can help detect Lung cancer early.

Keywords: Lung cancer, non-small cell lung cancer, small cell lung cancer, biomarkers, tumor


How to Cite

Vaidya, V., Bhandary, V., Qureshi, F., & Vishwakarma, P. (2022). Biomarker: A Potential Novel Therapeutic Target for Early Detection of Lung Cancer. Asian Oncology Research Journal, 5(1), 73–79. Retrieved from https://journalaorj.com/index.php/AORJ/article/view/65

Downloads

Download data is not yet available.

References

Who.int. Cancer.

[Accessed 3 February 2022].

Available:https://www.who.int/newsroom/factsheets/detail/cancer.

Matthew Hoffman, Human Anatomy. Picture of the lungs.

[Accessed 21 July 2022].

Available:https://www.webmd.com/lung/pictureofthelungs#:~:text=The%20lungs%20are%20a%20pair,bronchioles)%2C%20finally%20becoming%20microscopic.

Charles S. Dela Cruz et al. Lung Cancer: Epidemiology, Etiology, and Prevention. Clin Chest Med. 2011;32(4):2.

Georgia Hardavella, Rachel George, Tariq Sethi. Lung cancer stem cells—characteristics, phenotype. Transl Lung Cancer Res. 2016;5(3):273.

Cancerresearchuk.org. Types of Lung Cancer.

[Accessed 28 January 2022].

Available:https://www.cancerresearchuk.org/about-cancer/lung-cancer/stages-types-grades/types.

Cancer.net. Lung Cancer Non-Small Cell: Statistics.

[Accessed February 2022].

Available:https://www.cancer.net/cancertypes/lungcancernonsmallcell/statistics#:~:text=NSCLC%20is%20the%20most%20common,be%20diagnosed%20with%20lung%20cancer.

Castranova V, Rabovsky J, Tucker JH, Miles PR. The alveolar type II epithelial cell: a multifunctional pneumocyte. Toxicol Appl Pharmacol. 1988;3(93):472.

Cecilia Zappa, Shaker A. Mousa. Non-small cell lung cancer: current treatment and future advances. Transl Lung Cancer Res. 2016;5(3):288.

Lungetivity.org. Squamous Cell Lung Cancer.

[Accessed 12 February 2021].

Available:https://www.lungevity.org/forpatientscaregivers/lung-cancer-101/types-of-lung-cancer/squamous-cell-lung-cancer.

Sabbula BR, Anjum F. Squamous Cell Lung Cancer. Stat Pearls.

[Accessed 19 June 2022].

Available:https://www.ncbi.nlm.nih.gov/books/NBK564510/#:~:text=Squamous%20cell%20carcinoma%20(SCC)%20of,the%20left%20or%20right%20bronchus.

John R. Goldblum. Large Cell Carcinoma; 2018.

Available:https://www.sciencedirect.com/topics/medicine-and-dentistry/large-cell-carcinoma.

Winston W Tan. Small Cell Lung Cancer (SCLC).

[Accessed 07 May 2021].

Available:https://emedicine.medscape.com/article/280104-overview.

Neil Basumallik, Manuj Agarwal. Small Cell Lung Cancer. StatPearls.

[Accessed 12 July 2022].

Available:https://www.ncbi.nlm.nih.gov/books/NBK482458/#_NBK482458_pubdet_.

Cancer.org. Lung metastasis.

[Accessed 20 September 2020].

Available:https://www.cancer.org/treatment/understanding-your-diagnosis/advanced-cancer/lung-metastases.html.

Asuka Tsuya et al. Skeletal metastases in non-small cell lung cancer: A retrospective study. Lung Cancer. 2007;2(57):229.

Chiara D’Antonio et al. Bone and brain metastasis in lung cancer: recent advances in therapeutic strategies. Ther Adv Med Oncol. 2014;6(3):102.

Lee Villano J et al. Incidence of brain metastasis at initial presentation of lung cancer. Neuro-Oncology. 2015;17(1):122.

Cancer.org. Chemotherapy drugs used to treat NSCLC.

[Accessed 27 May 2020].

Available:https://www.cancer.org/cancer/lungcancer/treatingnonsmallcell/chemotherapy.html.

Henning Willers et al. Basic Mechanisms of Therapeutic Resistance to Radiation and Chemotherapy in Lung Cancer. Cancer J. 2013;19(3):203.

Cancercenter.com. What are some of the drugs used in Immunotherapy?.

[Accessed 20 July 2022].

Available:https://www.cancercenter.com/treatmentoptions/precisionmedicine/immunotherapy

Cancer.gov. Non-small Cell Lung Cancer.

[Accessed 28 January 2022].

Available:https://www.cancer.gov/aboutcancer/treatment/drugs/ipilimumab.

Tai Lahans. General Pathophysiology and Treatment: Conventional and Chinese Medicine. Integrating Conventional and Chinese Medicine in Cancer Care; 2007.

Available:https://www.sciencedirect.com/topics/neuroscience/interleukin2#:~:text=Interleukin%2D2%20(IL%2D2)%20is%20one%20of%20a,)%20cells%20and%20B%2Dcells.

Gardiner RE et al. Low immunogenicity in non-small cell lung cancer; do new developments and novel treatments have a role?. Cancer Metastasis Rev. 2015; 34:129.

Cancer.gov. What are the types of targeted therapy?.

[Accessed 31 May 2022].

Available:https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies.

Tetsuya Mitsudomi, Yasushi Yatabe. Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancer. FEBS Journal. 2010;277: 301.

Bryan A. Chan, Brett G.M. Hughes. Targeted therapy for non-small cell lung cancer: current standards and the promise of the future. Transl Lung Cancer Res. 2015;4(1):37-38.

David S. Ettinger et al. Non–Small Cell Lung Cancer. J Natl Compr Canc Netw. 2017;15(4):517.

Emmanuelle Laurenceau et al. Biosensors for circulating tumor cells (CTCs)-biomarker detection in lung and prostate cancer: Trends and prospects. Biosensors and Bioelectronics. 2022;197: 113770.

Sayuri Herath et al. The Role of Circulating Biomarkers in Lung Cancer. Front. Oncol. 2022;11:801269.

Shiwei Duan et al. MIR4435-2HG Is a Potential Pan-Cancer Biomarker for Diagnosis and Prognosis. Front. Immunol. 2022;13:1.

Cancer.org. PD-L1 Inhibitors.

[Accessed 22 March 2022].

Available:https://www.cancer.org/treatment/treatments-and-side-effects/treatment-types/immunotherapy/immune-checkpoint-inhibitors.html.

Yunhua Jia et al. LINC00665: An Emerging Biomarker for Cancer Diagnostics and Therapeutics. Cells. 2022;11: 17.

Hong Huang et al. Blood protein biomarkers in lung cancer. Cancer Letters. 2022;215886.

Jifeng Yu et al. Claudin18.2 is a novel molecular biomarker for tumor-targeted immunotherapy. Biomarker Research. 2022;10(38):1.

Qun Zhao. Roles of apelin/APJ system in cancer: Biomarker, predictor, and emerging therapeutic target. Journal of Cellular Physiology.

[Accessed 7 August 2022].

Available:https://doi.org/10.1002/jcp.30845

Bai-Rong Xia et al. Nicotinamide N-Methyltransferase: A Promising Biomarker and Target for Human Cancer Therapy. Frontiers in Oncology. 2022;12: 894744.

Yannick Saalberg, Marcus Wolff. VOC breath biomarkers in lung cancer. Clin Chim Acta. 2016;459:5-9.

Sonam Mittal, Maitreyi S Rajala. Heat shock proteins as biomarkers of lung cancer. 2020;6(21):477.

YongKui Zhang et al. Expression of miR-29c, miR-93, and miR-429 as Potential Biomarkers for Detection of Early Stage Non-Small Lung Cancer. 2014;2(9): 2-3.

Shan Lu et al. Plasma secretory phospholipase A2-IIa as a potential biomarker for lung cancer in patients with solitary pulmonary nodules. BMC Cancer. 2011;11(513):2-4.